Fundraising Fox
OncoTracker
West Hollywood, US · Founded 2014 · Delaware corporation
Find your way into OncoTracker
Sign up to see every warm intro you have to OncoTracker
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OncoTracker team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ONCOtracker is an incubator-stage biotech company developing approaches for monitoring and treating patients with multiple myeloma, other B-cell malignancies, and related disorders. It is part of a family of oncology-focused companies associated with the Berenson Cancer Center in the United States.
Founders & leadership
OncoTracker was founded in 2014 by James R. Berenson.
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 3 rounds · 2015–2020
▶$150KraisedFeb 2020 · 1 investors · Other Health CareRule 506(b)
▶$150KraisedFeb 2020 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James BerensonExecutive Officer, Director, Promoter
- Thomas W. GosneyExecutive Officer
- Offering amount
- $2M
- Amount sold
- $150K
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35KraisedMar 2019 · 1 investors · OtherRule 506(b)
▶$35KraisedMar 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James KuoExecutive Officer
- James BerensonExecutive Officer, Director, Promoter
- Offering amount
- $568.7K
- Amount sold
- $35K
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.1MraisedNov 2016 · 20 investors · OtherRule 506(b)
▶$1.1MraisedNov 2016 · 20 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Geoffrey GeeExecutive Officer, Director
- James BerensonExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.1M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
MD Anderson Cancer CenterUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Exact SciencesExact Sciences develops molecular diagnostic tests for cancer screening and detection, including multitarget stool DNA testing for colorectal cancer and multigene assays for breast cancer recurrence. The company serves patients and healthcare providers in the cancer diagnostics field.
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
ToperaAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
American Cancer Society (ACS)The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.
TargetedoncTargeted Oncology is a medical news and education publication for oncologists and cancer care professionals, covering clinical trial data, FDA approvals, treatment guidelines, and expert commentary across cancer types. It delivers conference coverage, podcasts, videos, and short-form content focused on precision oncology and targeted cancer therapies.
Companies working in the same space as OncoTracker.
Frequently asked questions
- What does OncoTracker do?
- ONCOtracker is an incubator-stage biotech company developing approaches for monitoring and treating patients with multiple myeloma, other B-cell malignancies, and related disorders. It is part of a family of oncology-focused companies associated with the Berenson Cancer Center in the United States.
- Who founded OncoTracker?
- OncoTracker was founded by James R. Berenson in 2014.
- How much funding has OncoTracker raised?
- OncoTracker has disclosed $1.3M raised across 3 rounds.
- Where is OncoTracker headquartered?
- OncoTracker is headquartered in West Hollywood, US.